Floatz logo

stp705

Liver Metastases

SirnaomicsPhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
73/ 100

Competitive context

36 Active assets in the Liver Metastases cohort.

Asset / SponsorPhaseRating
Irinotecan
Kamya Sankar
Phase 3BB
Eloxatin
Sun Yat-sen University
Phase 3BB
FLUOROURACILUM
Sun Yat-sen University
Phase 3BB
Calcium folinate pentahydrate
Fudan University
Phase 3BB
Ipilimumab
Vastra Gotaland Region
Phase 3B

View all 50 →

Same molecule, other indications

stp705 is also rated in:

Abdominal ObesityDormant
CC
Indicative ·
46 / 100
View asset →
cholangiocarcinomaDormant
CC
Indicative ·
42 / 100
View asset →
hepatocellular carcinomaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →